… as maintenance therapy in patients with squamous cell carcinomas. One criticism of this trial
is that about 50% of the patients in the placebo study arm never received additional therapy …

… of multiple agent maintenance therapy versus a single-agent maintenance therapy on OS
… -group analysis of multiple agent maintenance therapy versus a single-agent maintenance …

… maintenance therapy with either a continuation or a switch strategy in the treatment of non–small-cell
lung cancer … Depending on the tumor histologic type (squamous or nonsquamous), …

… Non–small cell lung cancer (NSCLC) is often diagnosed at later stages when treatment
options are limited. Maintenance therapy may prolong the time to disease progression and …

… -cell lung cancer (NSCLC) is usually limited to four to six cycles. Maintenance therapy
can … ) study to assess use of erlotinib as maintenance therapy in patients with non-progressive …

… for advanced non small cell lung cancer: maintenance treatment or early second-line? …
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, …

… therapy has only recently become a treatment paradigm for advanced non–small-cell lung
cancer. Maintenance therapy, which is designed to prolong a clinically favorable state after …

… Most patients with advanced non-small cell lung cancer (NSCLC) are initially treated with …
maintenance therapy. Patients with non-squamous cell carcinoma who receive maintenance …

… role of aggressive local therapy that included many … therapy to standard-of-care maintenance
treatment or observation in patients that did not progress after first-line systemic treatment…

… the role of maintenance therapy in the treatment of non-small cell lung cancer with various
results. … assess the likelihood and magnitude of the benefit and harm of maintenance therapy. …